Literature DB >> 28439651

Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study.

Jong-Chan Youn1,2, Yoo Jin Hong3, Hye-Jeong Lee4, Kyunghwa Han4, Chi Young Shim2, Geu-Ru Hong2, Young Joo Suh4, Jin Hur4, Young Jin Kim4, Byoung Wook Choi4, Seok-Min Kang2.   

Abstract

OBJECTIVES: We aimed to evaluate the prognostic role of cardiac magnetic resonance imaging (CMR)-based extracellular volume fraction (ECV) in patients with non-ischemic dilated cardiomyopathy (NIDCM) and compare it with late gadolinium enhancement (LGE) parameters.
METHODS: This was a single-center, prospective, cohort study of 117 NIDCM patients (71 men, 51.9 ± 16.7 years) who underwent clinical 3.0-T CMR. Myocardial ECV and LGE were quantified on the left ventricular myocardium. The presence of midwall LGE was also detected. Nineteen healthy subjects served as controls. The primary end points were cardiovascular (CV) events defined by CV death, rehospitalization due to heart failure, and heart transplantation.
RESULTS: During the follow-up period (median duration, 11.2 months; 25th-75th percentile, 7.8-21.9 months), the primary end points occurred in 19 patients (16.2%). The ECV (per 3% and 1% increase) was associated with a hazard ratio of 1.80 and 1.22 (95% confidence interval [CI], 1.48-2.20 and 1.14-1.30, respectively; p < 0.001) for the CV events. Multivariable analysis also indicated that ECV was an independent prognostic factor and had a higher prognostic value (Harrell's c statistic, 0.88) than LGE quantification values (0.77) or midwall LGE (0.80).
CONCLUSION: CMR-based ECV independently predicts the clinical outcome in NIDCM patients. KEY POINTS: • T1-mapping-based ECV is a useful parameter of risk stratification in NIDCM • ECV has a higher prognostic value than LGE • Contrast-enhanced T1-mapping CMR is a feasible and safe method.

Entities:  

Keywords:  Extracellular space; Magnetic resonance imaging; Myocardium; Prognosis; T1 mapping

Mesh:

Substances:

Year:  2017        PMID: 28439651     DOI: 10.1007/s00330-017-4817-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  24 in total

1.  Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

Authors:  Martin Ugander; Abiola J Oki; Li-Yueh Hsu; Peter Kellman; Andreas Greiser; Anthony H Aletras; Christopher T Sibley; Marcus Y Chen; W Patricia Bandettini; Andrew E Arai
Journal:  Eur Heart J       Date:  2012-01-24       Impact factor: 29.983

2.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

3.  Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.

Authors:  Yoo Jin Hong; Chul Hwan Park; Young Jin Kim; Jin Hur; Hye-Jeong Lee; Sae Rom Hong; Young Joo Suh; Andreas Greiser; Mun Young Paek; Byoung Wook Choi; Tae Hoon Kim
Journal:  Int J Cardiovasc Imaging       Date:  2015-01-30       Impact factor: 2.357

4.  Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats.

Authors:  H Arheden; M Saeed; C B Higgins; D W Gao; J Bremerich; R Wyttenbach; M W Dae; M F Wendland
Journal:  Radiology       Date:  1999-06       Impact factor: 11.105

Review 5.  Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.

Authors:  Sujith Kuruvilla; Nebiyu Adenaw; Arabindra B Katwal; Michael J Lipinski; Christopher M Kramer; Michael Salerno
Journal:  Circ Cardiovasc Imaging       Date:  2013-12-20       Impact factor: 7.792

6.  Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.

Authors:  J A McCrohon; J C C Moon; S K Prasad; W J McKenna; C H Lorenz; A J S Coats; D J Pennell
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

7.  T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.

Authors:  Fabian aus dem Siepen; Sebastian J Buss; Daniel Messroghli; Florian Andre; Dirk Lossnitzer; Sebastian Seitz; Marius Keller; Philipp A Schnabel; Evangelos Giannitsis; Grigorios Korosoglou; Hugo A Katus; Henning Steen
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-09-22       Impact factor: 6.875

8.  Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy.

Authors:  Valentina O Puntmann; Tobias Voigt; Zhong Chen; Manuel Mayr; Rashed Karim; Kawal Rhode; Ana Pastor; Gerald Carr-White; Reza Razavi; Tobias Schaeffter; Eike Nagel
Journal:  JACC Cardiovasc Imaging       Date:  2013-03-14

9.  Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume.

Authors:  Christopher A Miller; Josephine H Naish; Paul Bishop; Glyn Coutts; David Clark; Sha Zhao; Simon G Ray; Nizar Yonan; Simon G Williams; Andrew S Flett; James C Moon; Andreas Greiser; Geoffrey J M Parker; Matthias Schmitt
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-03       Impact factor: 7.792

10.  Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.

Authors:  Ankur Gulati; Andrew Jabbour; Tevfik F Ismail; Kaushik Guha; Jahanzaib Khwaja; Sadaf Raza; Kishen Morarji; Tristan D H Brown; Nizar A Ismail; Marc R Dweck; Elisa Di Pietro; Michael Roughton; Ricardo Wage; Yousef Daryani; Rory O'Hanlon; Mary N Sheppard; Francisco Alpendurada; Alexander R Lyon; Stuart A Cook; Martin R Cowie; Ravi G Assomull; Dudley J Pennell; Sanjay K Prasad
Journal:  JAMA       Date:  2013-03-06       Impact factor: 56.272

View more
  18 in total

1.  Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation.

Authors:  Mai Azuma; Shingo Kato; Ryusuke Sekii; Sho Kodama; Kei Kinoshita; Keisuke Suzurikawa; Minako Kagimoto; Naoki Nakayama; Kohei Iguchi; Kazuki Fukui; Tae Iwasawa; Daisuke Utsunomiya; Kazuo Kimura; Kouichi Tamura
Journal:  Int J Cardiovasc Imaging       Date:  2021-03-16       Impact factor: 2.357

2.  Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis.

Authors:  Francesco Sardanelli; Simone Schiaffino; Moreno Zanardo; Francesco Secchi; Paola Maria Cannaò; Federico Ambrogi; Giovanni Di Leo
Journal:  Eur Radiol       Date:  2019-05-02       Impact factor: 5.315

3.  CMR-derived extracellular volume fraction (ECV) in asymptomatic heart transplant recipients: correlations with clinical features and myocardial edema.

Authors:  Yating Yuan; Jie Cai; Yue Cui; Jing Wang; Osamah Alwalid; Xuehua Shen; Yukun Cao; Yan Zou; Bo Liang
Journal:  Int J Cardiovasc Imaging       Date:  2018-07-28       Impact factor: 2.357

Review 4.  Clinical application and technical considerations of T1 & T2(*) mapping in cardiac, liver, and renal imaging.

Authors:  Ilona A Dekkers; Hildo J Lamb
Journal:  Br J Radiol       Date:  2018-07-23       Impact factor: 3.039

Review 5.  Cardiovascular Magnetic Resonance Parametric Mapping Techniques: Clinical Applications and Limitations.

Authors:  Eleni Nakou; Rishi K Patel; Marianna Fontana; Chiara Bucciarelli-Ducci
Journal:  Curr Cardiol Rep       Date:  2021-11-11       Impact factor: 2.931

6.  The Prognostic Role of Tissue Characterisation using Cardiovascular Magnetic Resonance in Heart Failure.

Authors:  Robert D Adam; James Shambrook; Andrew S Flett
Journal:  Card Fail Rev       Date:  2017-11

7.  Effect of anthracycline therapy on myocardial function and markers of fibrotic remodelling in childhood cancer survivors.

Authors:  Wadi Mawad; Luc Mertens; Joseph J Pagano; Eugenie Riesenkampff; Marjolein J E Reichert; Seema Mital; Paul F Kantor; Mark Greenberg; Peter Liu; Paul C Nathan; Lars Grosse-Wortmann
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2021-03-22       Impact factor: 6.875

8.  MRI gadolinium dosing on basis of blood volume.

Authors:  Chia-Ying Liu; Shenghan Lai; João A C Lima
Journal:  Magn Reson Med       Date:  2018-11-02       Impact factor: 4.668

9.  Native T1 and Extracellular Volume Measurements by Cardiac MRI in Healthy Adults: A Meta-Analysis.

Authors:  Matthew Gottbrecht; Christopher M Kramer; Michael Salerno
Journal:  Radiology       Date:  2018-11-13       Impact factor: 29.146

Review 10.  Prognostic value of non-contrast myocardial T1 mapping in cardiovascular diseases: a systematic review and meta-analysis.

Authors:  Meng-Xi Yang; Hong-Bing Luo; Jie-Ke Liu; Xue-Ming Li; Chun-Hua Wang; Ke Shi; Jing Ren; Peng Zhou
Journal:  Heart Fail Rev       Date:  2022-01-22       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.